[Magnetic resonance imaging of the liver: what kind of contrast agents?].
The aim of this work is to describe the characteristics of Magnetic Resonance contrast media available or experimental in evaluation of focal liver diseases: non specific extracellular contrast media, reticoloendothelial and hepatobiliary-specific contrast media. A rational use of these different categories is suggested by analysis of their molecular and pharmacokinetic features.
De Gaspari
A
A
Cattedra e Servizio di Radiologia, Università Vita-Salute, Istituto Scientifico, Ospedale San Raffaele, Milan, Italy.
De Cobelli
F
F
Del Maschio
A
A
D003287:Contrast Media; D003911:Dextrans; D004492:Edetic Acid / Q000031:analogs & derivatives*; D052203:Ferrosoferric Oxide; D020518:Focal Nodular Hyperplasia / Q000175:diagnosis; D019786:Gadolinium DTPA; D006801:Humans; D007501:Iron; D008107:Liver Diseases / Q000175:diagnosis*; D008113:Liver Neoplasms / Q000175:diagnosis; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D008536:Meglumine / Q000031:analogs & derivatives*; D009942:Organometallic Compounds; D010087:Oxides; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives*
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D009942:Organometallic Compounds; D010087:Oxides; C064572:gadobenic acid; D011732:Pyridoxal Phosphate; D008536:Meglumine; D004492:Edetic Acid; D007501:Iron; C065507:ferumoxides; D019786:Gadolinium DTPA; C060076:N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid; D052203:Ferrosoferric Oxide